vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and GENCOR INDUSTRIES INC (GENC). Click either name above to swap in a different company.
AbCellera Biologics Inc. is the larger business by last-quarter revenue ($44.9M vs $23.6M, roughly 1.9× GENCOR INDUSTRIES INC). GENCOR INDUSTRIES INC runs the higher net margin — 14.6% vs -19.9%, a 34.5% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs -25.0%). GENCOR INDUSTRIES INC produced more free cash flow last quarter ($10.1M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs -23.9%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Gencor Industries Inc is a leading manufacturer of heavy construction and infrastructure equipment, specializing in asphalt production plants, thermal combustion systems, and supporting road-building machinery. It primarily serves North American and global construction markets, supplying products to both public sector infrastructure projects and private commercial construction operators.
ABCL vs GENC — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $23.6M |
| Net Profit | $-8.9M | $3.4M |
| Gross Margin | — | 28.7% |
| Operating Margin | -63.7% | 13.2% |
| Net Margin | -19.9% | 14.6% |
| Revenue YoY | 788.4% | -25.0% |
| Net Profit YoY | 73.9% | -9.8% |
| EPS (diluted) | $-0.03 | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $23.6M | ||
| Q3 25 | $9.0M | $18.8M | ||
| Q2 25 | $17.1M | $27.0M | ||
| Q1 25 | $4.2M | $38.2M | ||
| Q4 24 | $5.0M | $31.4M | ||
| Q3 24 | $6.5M | $20.9M | ||
| Q2 24 | $7.3M | $25.6M | ||
| Q1 24 | $10.0M | $40.7M |
| Q4 25 | $-8.9M | $3.4M | ||
| Q3 25 | $-57.1M | $1.9M | ||
| Q2 25 | $-34.7M | $3.8M | ||
| Q1 25 | $-45.6M | $6.1M | ||
| Q4 24 | — | $3.8M | ||
| Q3 24 | $-51.1M | $1.5M | ||
| Q2 24 | $-36.9M | $2.6M | ||
| Q1 24 | $-40.6M | $6.2M |
| Q4 25 | — | 28.7% | ||
| Q3 25 | — | 24.2% | ||
| Q2 25 | — | 26.5% | ||
| Q1 25 | — | 29.7% | ||
| Q4 24 | — | 27.6% | ||
| Q3 24 | — | 25.6% | ||
| Q2 24 | — | 23.9% | ||
| Q1 24 | — | 30.3% |
| Q4 25 | -63.7% | 13.2% | ||
| Q3 25 | -851.8% | -1.2% | ||
| Q2 25 | -290.2% | 11.6% | ||
| Q1 25 | -1479.6% | 17.0% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | -1439.4% | 5.9% | ||
| Q2 24 | -1276.2% | 7.8% | ||
| Q1 24 | -551.5% | 17.4% |
| Q4 25 | -19.9% | 14.6% | ||
| Q3 25 | -637.8% | 10.2% | ||
| Q2 25 | -203.3% | 14.2% | ||
| Q1 25 | -1077.2% | 16.0% | ||
| Q4 24 | — | 12.1% | ||
| Q3 24 | -785.4% | 6.9% | ||
| Q2 24 | -504.3% | 10.0% | ||
| Q1 24 | -408.0% | 15.3% |
| Q4 25 | $-0.03 | $0.23 | ||
| Q3 25 | $-0.19 | $0.13 | ||
| Q2 25 | $-0.12 | $0.26 | ||
| Q1 25 | $-0.15 | $0.42 | ||
| Q4 24 | — | $0.26 | ||
| Q3 24 | $-0.17 | $0.10 | ||
| Q2 24 | $-0.13 | $0.17 | ||
| Q1 24 | $-0.14 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $147.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $966.9M | $215.2M |
| Total Assets | $1.4B | $228.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | $147.7M | ||
| Q3 25 | $83.2M | $136.3M | ||
| Q2 25 | $92.4M | $136.0M | ||
| Q1 25 | $159.3M | $143.7M | ||
| Q4 24 | $156.3M | $130.1M | ||
| Q3 24 | $126.6M | $115.4M | ||
| Q2 24 | $148.3M | $116.6M | ||
| Q1 24 | $123.6M | $117.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | $0 | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $0 | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $966.9M | $215.2M | ||
| Q3 25 | $964.0M | $211.8M | ||
| Q2 25 | $1.0B | $209.9M | ||
| Q1 25 | $1.0B | $206.1M | ||
| Q4 24 | $1.1B | $200.0M | ||
| Q3 24 | $1.1B | $196.1M | ||
| Q2 24 | $1.1B | $194.7M | ||
| Q1 24 | $1.1B | $192.1M |
| Q4 25 | $1.4B | $228.9M | ||
| Q3 25 | $1.4B | $222.6M | ||
| Q2 25 | $1.4B | $220.2M | ||
| Q1 25 | $1.3B | $223.9M | ||
| Q4 24 | $1.4B | $218.2M | ||
| Q3 24 | $1.4B | $208.1M | ||
| Q2 24 | $1.4B | $201.8M | ||
| Q1 24 | $1.5B | $206.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $11.1M |
| Free Cash FlowOCF − Capex | $-44.6M | $10.1M |
| FCF MarginFCF / Revenue | -99.4% | 43.0% |
| Capex IntensityCapex / Revenue | 21.9% | 4.1% |
| Cash ConversionOCF / Net Profit | — | 3.23× |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $-3.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $11.1M | ||
| Q3 25 | $-52.6M | $-275.0K | ||
| Q2 25 | $-32.4M | $-23.9M | ||
| Q1 25 | $-11.6M | $12.4M | ||
| Q4 24 | $-108.6M | $14.8M | ||
| Q3 24 | $-28.9M | $-3.2M | ||
| Q2 24 | $-30.0M | $-1.0M | ||
| Q1 24 | $-41.7M | $11.7M |
| Q4 25 | $-44.6M | $10.1M | ||
| Q3 25 | $-61.5M | $-1.3M | ||
| Q2 25 | $-45.8M | $-24.4M | ||
| Q1 25 | $-22.2M | $12.3M | ||
| Q4 24 | $-187.0M | $14.5M | ||
| Q3 24 | $-47.4M | $-3.3M | ||
| Q2 24 | $-50.1M | $-1.4M | ||
| Q1 24 | $-65.8M | $11.7M |
| Q4 25 | -99.4% | 43.0% | ||
| Q3 25 | -687.0% | -6.8% | ||
| Q2 25 | -267.9% | -90.4% | ||
| Q1 25 | -524.0% | 32.2% | ||
| Q4 24 | -3702.8% | 46.1% | ||
| Q3 24 | -728.4% | -15.8% | ||
| Q2 24 | -683.8% | -5.6% | ||
| Q1 24 | -661.5% | 28.7% |
| Q4 25 | 21.9% | 4.1% | ||
| Q3 25 | 99.7% | 5.4% | ||
| Q2 25 | 78.2% | 1.8% | ||
| Q1 25 | 251.1% | 0.4% | ||
| Q4 24 | 1552.7% | 1.0% | ||
| Q3 24 | 284.6% | 0.4% | ||
| Q2 24 | 274.6% | 1.5% | ||
| Q1 24 | 242.5% | 0.0% |
| Q4 25 | — | 3.23× | ||
| Q3 25 | — | -0.14× | ||
| Q2 25 | — | -6.24× | ||
| Q1 25 | — | 2.04× | ||
| Q4 24 | — | 3.88× | ||
| Q3 24 | — | -2.22× | ||
| Q2 24 | — | -0.41× | ||
| Q1 24 | — | 1.87× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
